Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
Top Cited Papers
Open Access
- 1 January 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (1) , 241-250
- https://doi.org/10.1182/blood-2004-06-2482
Abstract
In humans, the pathways of memory T-cell differentiation remain poorly defined. Recently, adoptive cell transfer (ACT) of tumor-reactive T lymphocyteKeywords
This publication has 55 references indexed in Scilit:
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Control of Homeostasis of CD8 + Memory T Cells by Opposing CytokinesScience, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- T CELL MEMORYAnnual Review of Immunology, 1998
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4The Journal of Experimental Medicine, 1997
- Cellular environments and apoptosis: tissue microenvironments control activated T-cell deathImmunology Today, 1997
- CD27: marker and mediator of T-cell activation?Immunology Today, 1994